ArticleDiabetologia2023

Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study.

Vanja Kosjerina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.